Santen and SPCs: the Neurim bubble has burst
In a recent judgment surrounding ophthalmic pharmaceutical product manufacturer, Santen, the Court of Justice of the European Union has further limited opportunities for pharmaceutical companies to obtain Supplementary Protection Certificates (SPCs) for new applications of old products.